E
ENGN//CIK 0001980845
enGene Therapeutics Inc.
Market Data
$1.82+$0.08 (+4.60%)
ENGN · Last trade
Prev Close
$1.74
Range (29d)
$1.69 – $1.92
Recent Filings
- 8-K16.6 MBenGene Therapeutics Inc.Jul 17, 4:05 PM ET·0001193125-26-307795
- 8-K234.0 KBenGene Therapeutics Inc.Jul 16, 8:06 AM ET·0001193125-26-305418
- 8-K/A203.0 KBenGene Therapeutics Inc.Jun 18, 4:06 PM ET·0001193125-26-275815
- 10-Q11.8 MBenGene Therapeutics Inc.Jun 15, 9:16 AM ET·0001193125-26-270386
- 8-K451.7 KBenGene Therapeutics Inc.Jun 15, 9:14 AM ET·0001193125-26-270384
- 8-K217.1 KBenGene Therapeutics Inc.Jun 10, 4:09 PM ET·0001193125-26-265830
- 8-K2.4 MBenGene Therapeutics Inc.May 7, 7:11 AM ET·0001193125-26-210316
- 8-K1.3 MBenGene Therapeutics Inc.Apr 9, 4:02 PM ET·0001193125-26-149597
- 8-K735.4 KBenGene Holdings Inc.Mar 9, 7:15 AM ET·0001193125-26-097546
- 10-Q10.3 MBenGene Holdings Inc.Mar 9, 7:09 AM ET·0001193125-26-097541
Insiders
10- Astley-Sparke PhilipDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- Bos JasperDirector
- Boyd Matthew RossChief Regulatory Officer
- BRUNK GERALD ADirector
- BRYCE RICHARD PAULChief Medical Officer
- Buck JillChief Development Officer
- BVF GP HOLDINGS LLC10% Owner
- BVF I GP LLCSee Explanation of Responses
Tickers
Addresses
business
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
mailing
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
Former Names
- enGene Holdings Inc.2026-03-09